bleomycin lundbeck
lundbeck limited - withdrawn form - 5 milligram
bleomycin lundbeck injection
lundbeck limited - bleomycin sulfate - pdr for soln inj/inf - 15 milligram
ccnu lundbeck capsules
lundbeck limited - lomustine - capsule - 10 milligram
xenazine- tetrabenazine tablet
lundbeck pharmaceuticals llc - tetrabenazine (unii: z9o08yrn8o) (tetrabenazine - unii:z9o08yrn8o) - tetrabenazine 12.5 mg - xenazine is indicated for the treatment of chorea associated with huntington’s disease. xenazine is contraindicated in patients: - who are actively suicidal, or in patients with untreated or inadequately treated depression [see warnings and precautions (5.1)]. - with hepatic impairment [see use in specific populations (8.6), clinical pharmacology (12.3)]. - taking monoamine oxidase inhibitors (maois). xenazine should not be used in combination with an maoi, or within a minimum of 14 days of discontinuing therapy with an maoi [see drug interactions (7.3)]. - taking reserpine. at least 20 days should elapse after stopping reserpine before starting xenazine [see drug interactions (7.2)]. - taking deutetrabenazine or valbenazine [see drug interactions (7.7)]. risk summary there are no adequate data on the developmental risk associated with the use of xenazine in pregnant women. administration of tetrabenazine to rats throughout pregnancy and lactation resulted in an increase in stillbirths and postnatal offspri
escitalopram lundbeck 10 mg filmdragerad tablett
sabril tablet
lundbeck pharmaceuticals llc - vigabatrin - tablet - 500mg - vigabatrin 500mg - miscellaneous anticonvulsants
sabril powder for solution
lundbeck pharmaceuticals llc - vigabatrin - powder for solution - 500mg - vigabatrin 500mg - miscellaneous anticonvulsants
escitalopram lundbeck 20 mg/ml orala droppar, lösning
escitalopram lundbeck 10 mg filmdragerad tablett
escitalopram lundbeck 5 mg filmdragerad tablett